MIR4711

Across TCGA pan-cancer cohorts, MIR4711 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated MIR4711 data layer.

The strongest signal is observed in cholangiocarcinoma (CHOL), where higher MIR4711 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR4711 expression acts as an unfavorable survival marker.

CHOL, ACC, and LGG are the cancer types where MIR4711 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CHOL	OS	Tertile	All	0.024	0.728	<.001	108	view →
ACC	DFS	Tertile	II,III,IV	0.048	0.632	<.001	45	view →
LGG	DFS	Tertile	All	0.226	0.767	<.001	30	view →
THYM	OS	Tertile	II,III,IV	0.352	0.855	.006	24	view →
UCEC	DFS	Tertile	All	0.739	0.903	<.001	24	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	18	view →
TGCT	DFS	Tertile	All	0.066	0.674	.008	18	view →
SKCM	OS	Tertile	IV	0.415	0.861	.014	9	view →
THCA	DFS	Tertile	IV	0.572	0.874	.016	9	view →
READ	OS	Tertile	III,IV	0.287	0.772	.030	9	view →
KIRP	OS	Tertile	All	0.270	0.719	.035	3	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

MIR4711–CHOL (OS)

Open the CHOL breakdown →